Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated Net Debt to Free Cash Flow
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt to Free Cash Flow | 0.4x | 1.9x | 10.6x | 1.5x | 2.1x | 2.5x | 0.7x | (10.4x) | (3.1x) | 9.3x | 1.0x | 0.5x | (4.9x) | (2.5x) | (2.2x) | (2.1x) | (2.0x) | (2.7x) | (2.5x) | (3.2x) |
Vertex Pharmaceuticals Incorporated (VRTX) Net Debt to Free Cash Flow comparison analysis
VRTX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Vertex Pharmaceuticals Incorporated's Net Debt to Free Cash Flow?
As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is 4.1x, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Net Debt to Free Cash Flow for Vertex Pharmaceuticals Incorporated have been (1.8x) over the past three years, and (2.0x) over the past five years.
2) Is Vertex Pharmaceuticals Incorporated's Net Debt to Free Cash Flow Good?
As of today, Vertex Pharmaceuticals Incorporated's Net Debt to Free Cash Flow is 4.1x, which is higher than industry median of 0.9x. It indicates that Vertex Pharmaceuticals Incorporated's Net Debt to Free Cash Flow is Bad.